Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its second-quarter 2021 earnings today after the closing bell.
The revenue increased by 21% to $6.2 billion compared to the previous year.
The net income was $1.52 billion or $1.21 per share compared to a loss of $3.3 billion or $2.66 per share of the same quarter in the previous year.
The adjusted earnings per share were $1.87 compared to $1.11 of the previous year.
CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…
Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…
The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…
Overview Harley-Davidson, Inc. reported consolidated fourth-quarter 2025 results that point to continued pressure on profitability…
The Coca-Cola Company (NYSE: KO) reported its fourth quarter 2025 earnings results today. Net revenues…
The South Korean telecommunications provider reported a significant increase in annual profit for 2025, supported…